| Kingsley C Ozioko, | |
|
1359 Aspen Dr, Salisbury, MD 21804-2062 | |
| (443) 859-4954 | |
| Not Available |
| Full Name | Kingsley C Ozioko |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1359 Aspen Dr, Salisbury, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063784809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 19030 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kingsley C Ozioko, 1359 Aspen Dr, Salisbury, MD 21804-2062 Ph: (443) 859-4954 | Kingsley C Ozioko, 1359 Aspen Dr, Salisbury, MD 21804-2062 Ph: (443) 859-4954 |
News Archive
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
The study findings reveal that RBD-based vaccines adjuvanted with the formulation can induce strong anti-SARS-CoV-2 neutralizing immunity in young and aged mice. The study is currently available on the bioRxiv* preprint server.
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according to a new study published in mBio.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
› Verified 8 days ago
Meryam Gharbi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 735 S Salisbury Blvd, Salisbury, MD 21801 Phone: 410-219-5261 | |
Dr. Jennifer Denteh, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1316 Mount Hermon Rd, Salisbury, MD 21804 Phone: 410-749-0205 | |
Amber Rose Benitez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Mount Hermon Rd, Salisbury, MD 21804 Phone: 410-334-2194 | |
Robert Doremus Horsey Iii, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 404a N Fruitland Blvd, Salisbury, MD 21801 Phone: 410-749-8401 | |
Dr. Dennis M Killian, PHARM.D., PH.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-543-7509 Fax: 410-543-7485 | |
Dr. Ogechi Sophia Obi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 E North Pointe Dr, Salisbury, MD 21804 Phone: 410-572-8518 |